 |
Methylnaltrexone |
|---|---|
| Trade Name | Relistor |
| Orphan Indication | Chronic opioid-induced constipation unresponsive to conventional therapy |
| USA Market Approval | USA |
| USA Designation Date | 1996-06-17 00:00:00 |
| Sponsor | Progenics Pharmaceuticals, Inc.;765 Old Saw Mill River Rd.;Tarrytown, New York, 10591 |
